(Q72368992)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7805184%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

title

Phase I study of RP 49532A, a new protein-synthesis inhibitor, in patients with advanced refractory solid tumors (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7805184%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

author name string

G Catimel

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7805184%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

R Coquard

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7805184%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

J P Guastalla

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7805184%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

Y Merrouche

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7805184%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

N Le Bail

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7805184%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

M K Alakl

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7805184%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

A Dumortier

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7805184%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

M Foy

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7805184%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

M Clavel

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7805184%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

publication date

1 January 1995

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7805184%20AND%20SRC:MED&resulttype=core&format=json

Cancer Chemotherapy and Pharmacology

26 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7805184%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

volume

35

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7805184%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7805184%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

page(s)

246-248

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7805184%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf00686555

26 October 2019

exact match

0 references

cites work

Antitumor activity and mechanism of action of the marine compound girodazole

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/7805184

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Clinical trials in cancer chemotherapy

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/7805184

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/BF00686555

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7805184%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

1 reference